Somatropin is recombinant human growth hormone consisting of 191 amino acids. Medically supervised therapy can benefit patients with documented growth hormone deficiency and certain approved conditions. Its biological effects include promoting growth and influencing protein, carbohydrate, and lipid metabolism. Appropriate treatment requires clinical monitoring because excessive exposure can produce significant metabolic and endocrine complications.